|
Dr. McCarthy is former president and CEO of Focus Diagnostics, Inc., a developer of novel assays and diagnostic-testing services, now a subsidiary of Quest Diagnostics. Prior to his tenure at Focus, Dr. McCarthy was president of Indianapolis-based Boehringer Mannheim Diagnostics, a global diagnostic company specializing in clinical chemistry products and analyzers. Before joining Boehringer Mannheim, he was division vice president R&D, and vice president & general manager at Becton Dickinson & Company in Maryland, the world’s largest manufacturer of diagnostic products for microbiology and infectious disease, where he was responsible for BD’s three microbiology businesses. Dr. McCarthy received his bachelor’s in biology from St. Anselm College, Manchester, New Hampshire, and a PhD in microbiology from the University of New Hampshire, in Durham. He was a post-doctoral fellow in medical and public health microbiology at Columbia University College of Physicians and Surgeons in New York, and also completed the Harvard University School of Business Advanced Management Program. Dr. McCarthy has authored more than 50 peer-reviewed publications and 60 scientific abstracts and presentations. In addition, he is founder of the Clinical Microbiology Newsletter (Elsevier Publishing) and served on the editorial board of the Journal of Clinical Microbiology. |
